Home > Compound List > Product Information
(N-Boc-β-amino)-Ala-OH_Molecular_structure_CAS_73259-81-1)
Click picture or here to close

(N-Boc-β-amino)-Ala-OH

Catalog No. 662836 Name Sigma Aldrich
CAS Number 73259-81-1 Website http://www.sigmaaldrich.com
M. F. C8H16N2O4 Telephone 1-800-521-8956
M. W. 204.22364 Fax
Purity Email
Storage Chembase ID: 38585

SYNONYMS

Title
(N-Boc-β-氨基)-丙氨酸
IUPAC name
(2S)-3-amino-2-{[(tert-butoxy)carbonyl]amino}propanoic acid
IUPAC Traditional name
(2S)-3-amino-2-[(tert-butoxycarbonyl)amino]propanoic acid
Synonyms
(S)-3-氨基-2-(叔丁氧羰基氨基)丙酸
(S)-3-Amino-2-(tert-butoxycarbonylamino)propanoic acid
(S)-2-[(tert-Butoxycarbonyl)amino]-3-aminopropionic acid
(S)-3-Amino-2-(tert-butoxycarbonyl)aminopropionic acid
Nα-BOC-(S)-β-aminoalanine
Nα-Boc-L-β-aminoalanine
N2-(tert-Butoxycarbonyl)-(S)-2,3-diaminopropionic acid
N2-tert-Butoxycarbonyl-L-2,3-diaminopropionic acid
Boc-Dap-OH
Boc-Dpr-OH
3-Amino-(tert-butoxycarbonyl)-L-alanine
Nα-Boc-L-2,3-diaminopropionic acid
3-氨基-(叔丁氧羰基)-L-丙氨酸
Nα-Boc-L-2,3-二氨基丙酸

DATABASE IDS

PubChem SID 24884604
CAS Number 73259-81-1
MDL Number MFCD00236843
Beilstein Number 4182136

PROPERTIES

Empirical Formula (Hill Notation) C8H16N2O4
Melting Point 210 °C (dec.)
MSDS Link Download
Personal Protective Equipment Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
German water hazard class 3

DETAILS

Description (English)
Packaging
1 g in glass bottle
Application
Reactant for:
• Protein assembly directed by synthetic molecular recognition motifs1
• Solid phase synthesis of gramicidin S cyclic analogs with antibiotic and hemolytic activities2
• Synthesis of HCV protease inhibitor modified analogs3
• Solid phase synthesis of peptidic V1a receptor agonists4
• Directed peptide assembly at lipid-water interface5
Description (简体中文)
包装
1 g in glass bottle
Application
Reactant for:
• Protein assembly directed by synthetic molecular recognition motifs1
• Solid phase synthesis of gramicidin S cyclic analogs with antibiotic and hemolytic activities2
• Synthesis of HCV protease inhibitor modified analogs3
• Solid phase synthesis of peptidic V1a receptor agonists4
• Directed peptide assembly at lipid-water interface5

REFERENCES